Mycophenolate: dual utility in rare conditions of HIV infection complicating lupus

Calza N. , Manfredi R. , Colangeli V. , Chiodo F. Systemic lupus erythematosus and HIV infection. A case report and review of literature. Recent Prog Med 2002; 93: 28-31.

Palacios R. , Santos J. , Valdivielso P. , Marquez M. Human immunodeficiency infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 2002 ; 11: 60-63.

Molina JF , Citera G. , Rosler D. , et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol 1995; 22: 347-350.

D’Agati V. , Appel GB Renal pathology of human immunodeficiency virus. Semin Nephrol 1998; 18: 406-421.

Neboloni M. , Barbiano di Belgiojoso G. , Genderini A. , et al. Glomerular lesions in HIV positive patients: a 20-year biopsy experience from Northern Italy. Clin Nephrol 2009; 72: 38-45.

Mak A. , Cheak AA , Tan JY , Su HC , Ho RC , Lau CS Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression . Rheumatology (Oxford) 2009; 48: 944-952.

Jones RB , Walsh M. , Smith KG What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis? Curr Opin Rheumatol 2009 ; 21: 256-261.

Chapuis A. , Rizzardi P. , D’Agostino C. , et al. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nature Med 2000; 6: 762-768.

García F. , Plana M. , Arnedo M. , et al. Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study. J Acquir Immune Defic Syndr 2004; 1: 823-830.